Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Alongi

Showing results (231-240 of 305) with videos related to

Pageof 31
Sort By:
Radiation Oncology (London, England)|August 12, 2020
Two months of radiation oncology in the heart of Italian "red zone" during COVID-19 pandemic: paving a safe path over thin iceMichela Buglione, Luigi Spiazzi, Andrea Emanuele Guerini, et al.
Scientific Reports|August 14, 2020
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patientsAndrea Emanuele Guerini, Sara Pedretti, Emiliano Salah, et al.
International Journal of Radiation Oncology, Biology, Physics|November 27, 2010
Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patientsCesare Cozzarini, Claudio Fiorino, Luigi Filippo Da Pozzo, et al.
La Radiologia Medica|April 9, 2021
Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomesRosario Mazzola, Francesco Cuccia, Vanessa Figlia, et al.
Journal of Personalized Medicine|December 23, 2022
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 PatientsFilippo Alongi, Michele Rigo, Vanessa Figlia, et al.
Cancers|May 13, 2023
Proton Beam Therapy in the Oligometastatic/Oligorecurrent Setting: Is There a Role? A Literature ReviewSimona Gaito, Giulia Marvaso, Ramon Ortiz, et al.
Expert Review of Anticancer Therapy|September 29, 2022
Impact of preoperative chemoradiation with higher dose intensity modulated radiotherapy on pathological complete response for locally advanced rectal cancer: a systematic reviewRoberta Carbonara, Alessia Surgo, Maria Paola Ciliberti, et al.
Technical Innovations & Patient Support in Radiation Oncology|May 19, 2022
First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-LinacTomas M Janssen, Katharine Aitken, Filippo Alongi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2025
ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal metastases with Stereotactic Body Radiotherapy: Delphi consensus supported by a systematic review and meta-analysisFilippo Alongi, Francesco Cuccia, Rupesh Kotecha, et al.
Radiation Oncology (London, England)|September 14, 2011
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatmentsMarta Scorsetti, Filippo Alongi, Simona Castiglioni, et al.
Pageof 31

Showing results (231-240 of 305) with videos related to

Sort By:
Pageof 31
Radiation Oncology (London, England)|August 12, 2020
Two months of radiation oncology in the heart of Italian "red zone" during COVID-19 pandemic: paving a safe path over thin iceMichela Buglione, Luigi Spiazzi, Andrea Emanuele Guerini, et al.
Scientific Reports|August 14, 2020
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patientsAndrea Emanuele Guerini, Sara Pedretti, Emiliano Salah, et al.
International Journal of Radiation Oncology, Biology, Physics|November 27, 2010
Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patientsCesare Cozzarini, Claudio Fiorino, Luigi Filippo Da Pozzo, et al.
La Radiologia Medica|April 9, 2021
Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomesRosario Mazzola, Francesco Cuccia, Vanessa Figlia, et al.
Journal of Personalized Medicine|December 23, 2022
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 PatientsFilippo Alongi, Michele Rigo, Vanessa Figlia, et al.
Cancers|May 13, 2023
Proton Beam Therapy in the Oligometastatic/Oligorecurrent Setting: Is There a Role? A Literature ReviewSimona Gaito, Giulia Marvaso, Ramon Ortiz, et al.
Expert Review of Anticancer Therapy|September 29, 2022
Impact of preoperative chemoradiation with higher dose intensity modulated radiotherapy on pathological complete response for locally advanced rectal cancer: a systematic reviewRoberta Carbonara, Alessia Surgo, Maria Paola Ciliberti, et al.
Technical Innovations & Patient Support in Radiation Oncology|May 19, 2022
First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-LinacTomas M Janssen, Katharine Aitken, Filippo Alongi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2025
ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal metastases with Stereotactic Body Radiotherapy: Delphi consensus supported by a systematic review and meta-analysisFilippo Alongi, Francesco Cuccia, Rupesh Kotecha, et al.
Radiation Oncology (London, England)|September 14, 2011
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatmentsMarta Scorsetti, Filippo Alongi, Simona Castiglioni, et al.
Pageof 31